APA (7th ed.) Citation

Katakami, N., Mita, T., Yoshii, H., Shiraiwa, T., Yasuda, T., Okada, Y., . . . Ryomoto, K. (2021). The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus. Diabetes Therapy, 12(9), 2499. https://doi.org/10.1007/s13300-021-01125-8

Chicago Style (17th ed.) Citation

Katakami, Naoto, et al. "The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus." Diabetes Therapy 12, no. 9 (2021): 2499. https://doi.org/10.1007/s13300-021-01125-8.

MLA (9th ed.) Citation

Katakami, Naoto, et al. "The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus." Diabetes Therapy, vol. 12, no. 9, 2021, p. 2499, https://doi.org/10.1007/s13300-021-01125-8.